Lack of p53-mediated G1 arrest in response to an environmental carcinogen

Oncology

Volumn 57, Issue 3, 1999, Pages 258-264

  Khan, Qasim A ^a   Vousden, Karen H ^a   Dipple, Anthony ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

Author keywords

5 Methylchrysene; G1 arrest; p21(waf1 cip1); p53

Indexed keywords

CARCINOGEN; CHRYSENE DERIVATIVE; CIGARETTE SMOKE; DACTINOMYCIN; DNA; PROTEIN P21; PROTEIN P53;

ARTICLE; BREAST CARCINOMA; CELL CYCLE G1 PHASE; CELL STRAIN MCF 7; CHEMICAL CARCINOGENESIS; CONTROLLED STUDY; DNA DAMAGE; HUMAN; HUMAN CELL; IMMUNOBLOTTING; MITOSIS INHIBITION; PRIORITY JOURNAL; PROTEIN STABILITY;

BLOTTING, WESTERN; BREAST NEOPLASMS; CARCINOGENS; CHRYSENES; DNA DAMAGE; DNA, NEOPLASM; FLOW CYTOMETRY; G1 PHASE; HUMANS; SMOKING; TUMOR CELLS, CULTURED; TUMOR SUPPRESSOR PROTEIN P53;

EID: 0032868052     PISSN: 00302414     EISSN: None     Source Type: Journal    
DOI: 10.1159/000012040     Document Type: Article

References (34)

1. Loeb L, Ernster V, Warner K, Abbotts J, Laszlo J: Smoking and Lung Cancer: An overview. Cancer Res 1984;44:5940-5958.
2. Hecht S, Bondinell W, Hoffmann D: Chrysene and 5-methylchrysenes: Presence in tobacco smoke and carcinogenicity. J Natl Cancer Inst 1974;53:1121-1133.
3. You L, Wang D, Galati AJ, Ross JA, Mass MJ, Nelson GB, Wilson KH, Amin S, Stoner JC, Nesnow S, Stoner GD: Tumor multiplicity, DNA adducts and K-ras mutation pattern of 5-methylchrysene in strain A/J mouse lung. Carcinogenesis 1994;15:2613-2618.
4. Bigger CAH, Flickinger DJ, Strandberg J, Pataki J, Harvey RG, Dipple A: Mutational specificity of the anti-1,2-dihydrodiol 3,4-epoxide of 5-methylchrysene. Carcinogenesis 1990;11: 2263-2265.
5. Sancar A: DNA repair in human cells. Annu Rev Genet 1995;29:69-105.
6. Kastan MB, Onyekwere O, Sidransky D, Vogelstein B, Craig RW: Participation of p53 protein in the cellular response to DNA damage. Cancer Res 1991;51:6304-6311.
7. Hartwell LH, Weinert TA: Checkpoints: Controls that ensure the order of cell cycle events. Science 1989;246:629-634.
8. Kastan MB, Zhan Q, El-Deiry WF, Carrier F, Jacks T, Walsh WV, Plunkett BS, Vogelstein B, Fornace AJ: A mammalian cell cycle checkpoint pathway utilizing p53 and GADD45 is defective in ataxia-telangiectasia. Cell 1992;71: 587-597.
9. Dulic V, Kaufmann WK, Wilson SJ, Tlsty TD, Lees E, Harper JW, Elledge SJ, Reed SI: p53-dependent inhibition of cyclin-dependent kinase activities in human fibroblasts during radiation-induced G1 arrest. Cell 1994;76:1013-1023.
10. Namba H, Hara T, Tukazaki T, Migita K, Ishikawa N, Ito K, Nagataki S, Yamashita S: Radiation-induced G1 arrest is selectively mediated by the p53-WAF1/Cip1 pathway in hunan thyroid cells. Cancer Res 1995;55:2075-2080.
11. Nelson WG, Kastan MB, DNA strand breaks: The DNA template alterations trigger p53-dependent DNA damage response pathways. Mol Cell Biol 1994;14:1815-1823.
12. Lane DP: p53, guardian of the genome. Nature 1992;358:15-16.
13. Di Leonardo A, Linke SP, Clarkin K, Wahl GM: DNA damage triggers a prolonged p53-dependent G1 arrest and long-term induction of Cip1 in normal human fibroblasts. Genes Dev 1994;8:2540-2551.
14. Levine AJ: p53, the cellular gatekeeper for growth and division. Cell 1997;88:323-333.
15. Kubutat MHG, Vousden KH: Keeping an old friend under control: Regulation of p53 stability. Mol Med Today 1998;4:250-256.
16. Levine AJ: Tumor suppressor genes. Sci Am Sci Med 1995, pp 28-36.
17. Marshall CJ: Tumor suppressor genes. Cell 1991;64:313-326.
18. Tlsty TD: Normal diploid human and rodent cells lack a detectable frequency of gene amplification. Proc Natl Acad Sci USA 1990;87: 3132-3136.
19. Wright JA, Smith HS, Watt FM, Hancock MC, Hudson DL, Stark GR: DNA amplification is rare in normal human cells. Proc Natl Acad Sci USA 1990;87:1791-1795.
20. Yin Y, Tainsky MA, Bischoff FZ, Strong LC, Wahl GM: Wild-type p53 restores cell cycle control and inhibits gene amplification in cells with mutant p53 alleles. Cell 1992;70:937-948.
21. Livingstone LR, White A, Sprouse J, Livanos E, Jacks T, Tlsty TD: Altered cell cycle arrest and gene amplification potential accompany loss of wild-type p53. Cell 1992;70:923-935.
22. Donehower LA: The p53-deficient mouse: A model for basic and applied cancer studies. Semin Cancer Biol 1996;7:269-278.
23. waf1/cip1. Carcinogenesis 1997;18: 2313-2318.
24. Khan QA, Agarwal R, Seidel A, Frank H, Vousden KH, Dipple A: DNA adduct levels associated with p53-induction and delay of MCF-7 cells in S-phase after exposure to benzo[g]chrysene dihydrodiol epoxide enantiomers. Mol Carcinog 1998;23:115-120.
25. Dipple A, Khan QA, Page JE, Pontén I, Szeliga J: Chemical reactions, mutagenic action and stealth properties of polycyclic aromatic hydrocarbon carcinogens (review). Int J Oncol 1999; 14:103-111.
26. Khan QA, Vousden KH, Dipple A: Potent chemical carcinogens evade the p53-mediated G1 arrest defense mechanism in human cells submitted.
27. Kessis TD, Slebos RJ, Nelson WG, Kastan MB, Plunkett BS, Han SM, Lorincz AT, Hedrick L, Cho KR: Human papillomavirus 16 E6 expression disrupts the p53-mediated cellular response to DNA damage. Proc Natl Acad Sci USA 1993;90:3988-3992.
28. Timchenko NA, Wilde M, Nakanishi M, Smith JR, Darlington GJ: CCAAT/enhancer-binding protein a (C/EBPa) inhibits cell proliferation through the p21 (WAF-1/CIP-1 /SDI-1) protein. Genes Dev 1996;10:804-815.
29. Butz K, Geisen C, Ullmann A, Zentgraf H, Hoppe-Seyler F: Uncoupling of p21/WAF-1/ CIP-1/SDI-1 mRNA and protein expression upon genotoxic stress. Oncogene 1998;17:781-787.
30. Brugarolas J, Chandrasekaran C, Gordon JI, Beach D, Jacks T, Hannon GJ: Radiation-induced cell cycle arrest compromised by p21 deficiency. Nature 1995;377:552-557.
31. Deng C, Zhang P, Harper JW, Elledge SJ, Leder P: Mice lacking p21waf1/cip1 undergo normal development, but are defective in G1 check point control. Cell 1995;82:675-684.
32. Tokusashi Y, Fukuda I, Ogawa K: Absence of p53 mutations and various frequencies of Kiras exon 1 mutations in rat hepatic tumors induced by different carcinogens. Mol Carcinog 1994;10:45-51.
33. Eaton DL, Gallagher EP: Mechanisms of aflatoxin carcinogenesis. Annu Rev Pharmacol Toxicol 1994;34:135-172.
34. Hulla JE, Chen ZY, Eaton DL: Aflatoxin B1-induced rat hepatic hyperplastic nodules do not exhibit a site-specific mutation within the p53 gene. Cancer Res 1993;53:9-11.